EUVIMEDEUVIMED entdecken
Crossref

Structurally Engineered Organic Photosensitizer Enabling Synergistic Photodynamic and Photoacid Therapy via ROS and H + Co‐Generation

Shasha Wu, Jinhui Wang, Weikang Chen, Hongliang Wang, Zixuan Xu iD, Zhifang Wu iD

Luminescence · 2025

DOI: 10.1002/bio.70350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2025. Verfasst von Shasha Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical Unive…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Reactive Oxygen Species, Antineoplastic Agents. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical Key Specialty Program of Shanxi Bethune Hospital, 2025 Annual "Promising Candidates" Cultivation Project for National Natural Science Foundation at Shanxi Bethune Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of multiactive photosensitizers integrating the functions of photodynamic therapy (PDT) and photoacid therapy (PAT) provides a new strategy for overcoming tumor drug resistance and enhancing therapeutic efficacy. In this study, we designed and synthesized an organic photosensitizer, CzC, with a twisted molecular structure consisting of carbazole and thiophene linked by covalent bonds. This molecular design endowed CzC with excellent light absorption, good photostability and efficient ROS and H + release under 365‐nm laser irradiation. This bifunctional response mechanism synergistically disrupts intracellular acid–base homeostasis and triggers oxidative stress to promote tumor cell apoptosis. In vitro, CzC showed good cellular uptake, potent ROS/H + generation, and very low dark toxicity; in vivo in a mouse 4T‐1 tumor model, CzC significantly inhibited tumor growth under light activation, and no systemic toxicity or organ damage was observed. This study demonstrates that CzC is an organic photosensitizer with structural designability, photostability, and bimodal therapeutic function, and provides a powerful candidate molecule for next‐generation phototherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsPhotochemotherapyReactive Oxygen SpeciesAntineoplastic AgentsCarbazolesThiophenesAnimalsMiceHumansMolecular StructureApoptosisDrug Screening Assays, AntitumorCell ProliferationCell Line, TumorCell Survival

Stichwörter der Autor:innen

cell apoptosisoxidative stressphotoacid generatorphotoacid therapyphotodynamic therapy

Substanzen

Photosensitizing AgentsReactive Oxygen SpeciesAntineoplastic AgentsCarbazolesThiophenescarbazole

Autor:innen und Institutionen

  • Department of Psychiatry, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
  • Department of Pharmacy, Shanxi Medical University, Taiyuan, China.
  • Academy of Medical Sciences, Shanxi Medical University, Taiyuan, China.
  • Department of Nuclear Medicine, The First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China.
  • Shanxi Key Laboratory of Molecular Imaging, Shanxi Medical University, Taiyuan, Shanxi, China.
  • Collaborative Innovation Center for Molecular Imaging of Precision Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.

ORCID-Profile: Zixuan Xu, Zhifang Wu

Förderung

  • National Natural Science Foundation of China
  • Clinical Key Specialty Program of Shanxi Bethune Hospital
  • 2025 Annual "Promising Candidates" Cultivation Project for National Natural Science Foundation at Shanxi Bethune Hospital
  • Basic Research Projects of Shanxi Province China
  • Scientific and Technologial Innovation Programs of Higher Education Institutions in Shanxi

Zitieren

APA

Wu, S., Wang, J., Chen, W., Wang, H., Xu, Z., & Wu, Z. (2025). Structurally Engineered Organic Photosensitizer Enabling Synergistic Photodynamic and Photoacid Therapy via ROS and H + Co‐Generation. Luminescence. https://doi.org/10.1002/bio.70350

Vancouver

Wu S, Wang J, Chen W, Wang H, Xu Z, Wu Z. Structurally Engineered Organic Photosensitizer Enabling Synergistic Photodynamic and Photoacid Therapy via ROS and H + Co‐Generation. Luminescence. 2025. doi:10.1002/bio.70350

BibTeX
@article{Wu2025,
  author = {Wu, Shasha and Wang, Jinhui and Chen, Weikang and Wang, Hongliang and Xu, Zixuan and Wu, Zhifang},
  title = {Structurally Engineered Organic Photosensitizer Enabling Synergistic Photodynamic and Photoacid Therapy via ROS and H + Co‐Generation},
  journal = {Luminescence},
  year = {2025},
  doi = {10.1002/bio.70350}
}
Kostenlos starten →